Endoscopic imaging firm Pentax Medical has released the US Food and Drug Administration (FDA) approved CAP HD Duodenoscope (ED34-i10T) with a disposable distal cap.
Duodenoscopes are used during the endoscopic retrograde cholangiopancreatography (ERCP) procedure.
ERCP requires video endoscopy combined with fluoroscopic imaging and is performed for the diagnosis and treatment of disorders associated with the pancreaticobiliary system.
Part of the firm’s i10 Series of endoscopes, the CAP Duodenoscope is designed to improve clarity, access and performance for enhanced standards of treatment and safety in routine as well as advanced ERCP.
In addition to HD+ high-definition imaging, the duodenoscope is said to feature better clinical control and improved access for cleaning and reprocessing with a detachable and disposable distal cap.
Pentax Medical global chief clinical officer Dr Hudson Garrett said: “Pentax Medical is pleased to bring this new innovation to the market as part of our multi-tiered Medical Device Hygiene and Infection Control Strategy, specifically designed to improve the delivery of clinical care and overall infection control efforts by reprocessing technicians and nursing professionals.”
The new duodenoscope features PENTAX i-SCAN and OE Optical Enhancement technology that are claimed to aid in the detailed visualisation of mucosa, identification of abnormal tissue, and location of the papilla for cannulation.
Pentax Medical Americas president David Woods said: “Pentax Medical is committed to advancing endoscopy with innovations that help improve clinical and economic outcomes and enhance patient and provider satisfaction.
“With the CAP HD Duodenoscope, we responded to a clinical need in a meaningful way.”